Balloon catheters and methods for treating paranasal sinuses

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Acclarent, Inc. patent solves the following problem:

To fully understand the invention, it is necessary to consider the anatomy and physiology of the sinus system. Fig. 4-16, showing the various steps in the process of creation, also showed the importance of the sinus anatomy. The maxillary sinus 21 lies lateral to the nasal cavity 38, under the eye orbits 23 and higher than the roof or roof of the mouth. The medial wall of the maxillary sinus forms the lateral nasal wall 44 inferiorly. The frontal sinus 35 (FIG. 16) is on the orbit and the floor that formed the frontal bones and the adjacent part of the orbit roof. The right and left sinuses directly divided interfrontal septum. The frontal sinus drains into the nasal cavity and the outflow tract is inferomedial sinus, which connects the frontonasal duct 36. Frontonasal duct 36 empties into the nasal cavity through the lateral nasal wall 44 under the middle turbinate 20.

Our analysis of this patent is as follows:

Acclarent, Inc.’s patent US 9457175 B2 deals with Balloon catheters and methods for treating paranasal sinuses.
A bunch of sinus balloon catheter for the treatment given to a patient paranasal sinus system, including dilating ready door, and natural Ostia and ducts and excising sinus cavities. It includes a balloon catheter with a bend to put on a distal portion 90 into a proximal portion and a balloon catheter that is substantially straight. The catheter has sufficient stiffness and column strength of the balloon carrying distal portion of the catheter can be pushed into the prepared opening, natural ostium or duct, or sinus demanded. The catheter has to be inflated working diameters and outer diameters should the balloon is deflated and catheter can be pushed into each prepared to open, natural ostium or duct, or sinus cavities taken. The method of using the balloon catheter to dilate ready to open to selected parts of the sinus system, to dilate natural ostia and ducts in the sinus system, and / or to dilate sinus cavity to remove them.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Affiris Ag patent solves the following problem:

Our analysis of this patent is as follows:

Affiris Ag’s patent US 9457078 B2 deals with Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein.
The present invention relates to a vaccine comprising at least one peptide comprising amino acid sequences LRANISHKDMQLGR (SEQ ID No. 1) or a peptide fragment thereof (SEQ ID No. 2-13 ) with or fused to a carrier protein that contains at least one T cell epitope, wherein said peptide fragment comprising at least 7 amino acid residues, and the amino acid is KDMQLGR (SEQ ID No: 7) or KDMQLG (SEQ ID No: 23) under the provisions of the peptide fragment consisting of amino acid sequences HKDMQLGR (SEQ ID No: 16) and HKDMQLG (SEQ ID No: 22).

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Multi-port mini computer

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Nai-Chien Chang patent solves the following problem:

Computer may exist in every family. The traditional personal computers (PCs) should mainboard, Central Process Unit (CPU), Random Access Memory (RAM), display card, audio card, heat-reduced fan and connectors as well as casing, which gives the PC bulky size and weight and made it difficult to carry.

Our analysis of this patent is as follows:

Nai-Chien Chang’s patent US 9459659 B2 deals with Multi-port mini computer.
A multi-port mini computer includes a first housing and an adjustment stage. The first housing includes a first connector, a microprocessor, a wireless network unit, an antenna, a second male connector and a first surface casing enclosing elements. The adaptation stage comprises a second woman, a third male connector, and a second surface casing enclosing elements. The first casing has a sliding rail on the outer surface thereof, and the second casing has a connection to the outer surface thereof. Adapting stage assembled into the first housing by connecting the connection member to the sliding rail. The first male connector, the second connector and the third male connector different kinds of male connectors, the second female connector is equivalent to the second male connector.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Abrasion resistant glove

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Ansell Healthcare Products Llc patent solves the following problem:

Our analysis of this patent is as follows:

Ansell Healthcare Products Llc’s patent US 9456645 B2 deals with Abrasion resistant glove.
A glove comprising an elastomeric coating with a particle filler and a way to make such a glove. In particular, the glove is made of a knitted liner formed from at least one thread; an elastomeric coating that covers at least a portion of the knitted liner; and wherein the elastomeric coating comprises a filler particle having a hardness greater than the hardness of the elastomeric coating.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Ion sustained-release dental resin temporary sealing material composition

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Shofu Inc. patent solves the following problem:

A dental Beauty temporary sealing material is a provisional filling material used, after removing caries occurred in a tooth and forming a hole, temporarily sealing the hole in dental treatment. Conventional dental Beauty temporary sealing material mainly classified into two types, ie photopolymerization and chemical polymerization. In current clinical practice, some dentists choose one of the kind and use of selected varieties depending on the case, the site, the application time, etc. The chemical polymerization type widely used in terms of cost and ease of operation filling and removal operations. Chemical polymerization type resin temporary sealing material, however, defects in sealability. Cases where the teeth had decalcified plaque from the marginal region confirmed in actual clinical practice, generating concerns about the occurrence of post-operative pain or secondary caries after greeting prosthesis.

Our analysis of this patent is as follows:

Shofu Inc.’s patent US 9456964 B2 deals with Ion sustained-release dental resin temporary sealing material composition.
A dental Beauty temporary sealing material composition is very good adhesion to tooth substance and removability of hardened material and have a preventive function to release the various ion with a fluoride ion given. The constraint on the cavity walls can be improved and, because there is little dimensional change during hardening, excellent sealability a hole can reach.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Virtual reference clock for virtual machines

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Vmware, Inc. patent solves the following problem:

In a computer system, the synchronization of any real or virtual clock to a reference period is an iterative and ongoing process as the computer system runs. Without simultaneous updates on a daily basis, the time between the order of a few seconds a day are common even in server class computer hardware in a temperature-controlled environment.

Our analysis of this patent is as follows:

Vmware, Inc.’s patent US 9459652 B1 deals with Virtual reference clock for virtual machines.
A virtual switch clock allows precise switching reference time from a variety of different sources, transforms the discussion during a representation of a collection of different formats, and made speaking when used in guest operating system when running as virtual machines. As a result, the reference to the time that the increases, improved security, and the opportunities for providing extra in the event of hardware or software failure. Also, the ability to morph format allows the concept to be applied to guest virtual machine without the need to change the guest operating system.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Antibody induced cell membrane wounding

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Igm Biosciences, Inc. patent solves the following problem:

Cell membrane wounding is a disruption in the plasma membrane of cells, and in general a surviving the incident. Cell membrane strike is a common occurrence in mammal mechanically active tissues such as endothelial lining of the aorta or the gastrointestinal tract, skin epithelia or myocytes in the heart or skeletal muscles, and also shown during the invasion of cells in trypanosomes. In laboratory conditions, cell wounding normally induced using mechanical means to bind to the cell membrane, such as using a Microneedle to penetrate the plasma membrane or by scratching a culture dish to differentiate one part of a cell.

Our analysis of this patent is as follows:

Igm Biosciences, Inc.’s patent US 9458241 B2 deals with Antibody induced cell membrane wounding.
Compositions and methods for inducing cell membrane wounding, cell permeabilization and cell death gave. The composition comprises a polyvalent agent that binds to a highly expressed cell surface antigen present on the surface of a cell. At best, the cell surface antigen with the cell cytoskeleton. A preferred polyvalent agent is an IgM, and enhanced cell wounding and murder will be given to the addition of a crosslinking agent. Sublethal concentration in vivo, the cell wounding antibody permeabilize cells and dramatically improve the response to chemotherapeutic agents, even in patients rebelled chemotherapeutic agents.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)

File for Quick & Easy Patent Protection with PowerPatent.

The Institut National De La Sante Et De La Recherche Medicale (Inserm) patent solves the following problem:

Our analysis of this patent is as follows:

Institut National De La Sante Et De La Recherche Medicale (Inserm)’s patent US 9458239 B2 deals with Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II).
The present invention relates to monoclonal antibodies and fragments thereof directed against the human Anti-Mllerian hormone receptor type II (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian range cancer.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Trolley for transporting individuals of limited capacity in sedentary position on chair

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The David Mizrachi patent solves the following problem:

A wheelchair is a wheeled mobility device user is sitting. device is propelled either manually (by turning the wheels by hand) or through various automated systems. Wheelchair used in men for whom walking is difficult or impossible due to illness (physiological or physical), injury, or disability.

Our analysis of this patent is as follows:

David Mizrachi’s patent US 9456941 B2 deals with Trolley for transporting individuals of limited capacity in sedentary position on chair.
A trolley for transporting individuals with limited capacity in an active position in a chair exposed. The aforesaid trolley belonging to (a) a bearing structure and (b) at least three wheels rotatably structures within a perimeter. The bearing structure configured to releasably fixating the legs of the chair as the chair is reversibly mountable carrying structure.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Deveining system and device

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Laitram, L.L.C. patent solves the following problem:

To prepare the shrimp, crawfish or other animals that have a root in the alimentary canal, it is often desirable to remove the vein. Current options for deveining shrimp include manual removal, which is inefficient and time-consuming, and automated device known in the art. With manual operation, a worker must perform a number of operations to partially or completely remove the shell from the meat of shrimp, and cut the meat with shrimp way desirable to the end user. Manual vein removal is relatively time consuming and thus lead to higher costs. Moreover, the recent contacts between the workers and the shrimp can lead to contamination of shrimps. Furthermore, the process results to be less than uniform depending on individual workers to perform the operation, and the diligence of the workers process shrimp.

Our analysis of this patent is as follows:

Laitram, L.L.C.’s patent US 9456617 B2 deals with Deveining system and device.
A deveining device efficiently removes the vein from the shrimp while preserving the meat of shrimp in both form and number. Deveining device consists of a channel that has a blade extending along a section of the canal to cut back on shrimp as it rolls through the channel to expose a vein. A low root remover severs the exposed vein from the shrimp body. Nozzles spray fluid channel to maintain shrimp by the way.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.